Forfivo XL

Forfivo XL is a brand name of bupropion, approved by the FDA in the following formulation(s):

FORFIVO XL (bupropion hydrochloride - tablet, extended release; oral)

• 
  Manufacturer: INTELGENX CORP
  
  Approval date: November 10, 2011
  
  Strength(s): 450MG ^[RLD]

Has a generic version of Forfivo XL been approved?

No. There is currently no therapeutically equivalent version of Forfivo XL available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Forfivo XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Sustained-release bupropion and bupropion/mecamylamine tablets
  Patent 7,674,479
  Issued: March 9, 2010
  Inventor(s): Zerbe; Horst G. & Paiement; Nadine
  Assignee(s): Intelgenx Corp.
  Sustained-release bupropion hydrochloride pharmaceutical tablets and combination sustained-release bupropion hydrochloride/mecamylamine hydrochloride pharmaceutical tablets are obtained by granulating the bupropion hydrochloride with a hydroxyalkylcelluose, and blending the resulting granules within an extragranular phase composed of a particulate material that provides a sustained-release matrix, and compressing the blend into a tablet form, which then is coated, with a means to provide delayed release, such as with an enteric coating composition. The mecamylamine hydrochloride can be contained in a second granule comprising a hydroxyalkylcellulose.
  
  Patent expiration dates:
  
  
  • June 25, 2027
    
    ✓ 
    Drug product
  
  

See also...

• Forfivo XL Consumer Information (Drugs.com)
• Bupropion Consumer Information (Drugs.com)
• Bupropion Consumer Information (Wolters Kluwer)
• Bupropion Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Bupropion Hydrobromide Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Bupropion Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Bupropion Consumer Information (Cerner Multum)
• Bupropion Advanced Consumer Information (Micromedex)
• Bupropion Hydrochloride AHFS DI Monographs (ASHP)